Dr. Tülay Yarkın
Pulmonology & Thoracic SurgeryVerified
- 28+years exp.
English · Turkish
60 seconds · no obligationView Profile
What a pulmonary lobectomy is, how VATS and open surgical techniques remove a diseased lung lobe, what clinical evidence says regarding lung cancer and benign disease, approximate treatment costs across Turkey, the UK, the US and Germany, hospital stay duration, recovery milestones, fit-to-fly precautions, potential surgical risks and how to evaluate a hospital thoracic surgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Pulmonology & Thoracic SurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
A lobectomy is a major surgical procedure in which an entire lobe of an organ is excised. In thoracic surgery, it refers to pulmonary lobectomy: the removal of one of the five lobes of the lungs. The right lung has three lobes (upper, middle and lower) and the left has two (upper and lower). During a lung lobectomy, the thoracic surgeon isolates and divides the specific branches of the pulmonary artery, pulmonary vein and lobar bronchus with surgical staplers, removing the diseased lobe while preserving healthy lung tissue.
Patients researching a lobectomy in Turkey are typically treating early-stage lung tumours, severe localised bronchiectasis, or persistent fungal infections. Modern procedures use either minimally invasive video-assisted thoracoscopic surgery (VATS) or open thoracotomy. For an overview of respiratory care options, see our guide to pulmonology treatments in Turkey (hub).
A lobectomy is the established international gold standard for operable, early-stage non-small cell lung cancer (NSCLC, stages I and II). Major clinical guidelines from the European Society for Medical Oncology (ESMO) and the National Institute for Health and Care Excellence (NICE) recommend anatomical lobectomy with systematic lymph node dissection for long-term local tumour control.
For benign conditions, including localised bronchiectasis resistant to medical therapy, severe pulmonary abscesses, or fungal cavities (aspergilloma), resecting the damaged lobe eliminates chronic coughing, hemoptysis and recurrent infections. However, surgery cannot resolve diffuse conditions affecting both lungs, such as generalised emphysema. Clinical staging must confirm that disease is confined to a single resectable lobe.
Thoracic surgery pricing depends on whether resection uses VATS or open thoracotomy, the length of intensive care stay, pathology analyses and post-operative monitoring. The figures below are approximate ranges for hospital packages, not fixed quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €7,500 – €16,000 |
| United Kingdom | €18,000 – €34,000 |
| United States | €32,000 – €75,000 |
| Germany | €16,000 – €32,000 |
When comparing lobectomy price quotes, patients should verify package inclusions. A standard package in Turkey includes preoperative staging review, pulmonary function tests, surgeon and anaesthetist fees, one to two nights in thoracic intensive care, ward accommodation, endostapler consumables, pathology reports, initial medication and airport transfers. Complex staging or extended intensive care may incur additional costs.
Thoracic surgeons select the extent of resection based on tumour size, location, histology and respiratory reserve. When an entire lung must be removed due to central tumour involvement, surgeons perform a pneumonectomy. As detailed in our guide to pneumonectomy, complete removal carries a higher physiological burden than a lobectomy, which spares the remaining lobes.
| Surgical technique | Best suited to | Typical limits |
|---|---|---|
| VATS or robotic lobectomy | Peripheral tumours under 5 cm, early-stage cancer, benign lesions | Requires clear tissue planes; vascular invasion may necessitate conversion to open surgery |
| Open thoracotomy lobectomy | Large central tumours, dense pleural adhesions, chest wall invasion | Larger incision between ribs; longer initial hospital stay and higher post-operative soreness |
| Segmentectomy or wedge resection | Nodules under 2 cm, patients with compromised lung function | Higher risk of local recurrence if margins are narrow; limited to peripheral lesions |
| Pneumonectomy | Extensive central tumours invading main bronchus or pulmonary artery trunk | Removes entire lung; substantial impact on long-term respiratory reserve |
Imaging and lung function tests determine whether a lobectomy offers the right balance between oncological clearance and functional preservation.
A pulmonary lobectomy treats both malignant and severe non-malignant conditions:
Assessing suitability for lobectomy surgery requires evaluating oncological staging and cardiopulmonary fitness. Patients must have sufficient respiratory reserve to breathe comfortably after losing a lobe.
Suitable candidates typically have single-lobe disease, good functional mobility (ECOG 0–1) and satisfactory spirometry. Predicted post-operative values for forced expiratory volume in one second (ppoFEV1) and carbon monoxide diffusing capacity (ppoDLCO) should exceed 30 to 40 percent. Borderline cases undergo cardiopulmonary exercise testing to measure oxygen consumption.
Surgery is generally unsuitable for patients with widespread distant metastases (Stage IV disease), malignant pleural effusion, severe uncompensated heart failure, recent heart attack, severe pulmonary hypertension, or advanced COPD where residual lung volume cannot sustain breathing. Preoperative clearance is conducted in an accredited pulmonology and thoracic surgery department.
A lobectomy follows a structured surgical sequence:
Understanding lobectomy recovery milestones is vital when travelling abroad. International patients must remain in Turkey until the remaining lung has fully re-expanded and the surgeon certifies they are safe to fly.
A standard schedule in Turkey requires 12 to 16 days:
Desk work can resume after 4 to 6 weeks, while strenuous exercise and heavy lifting should wait 8 to 12 weeks. Complete nerve and stamina recovery takes three to six months.
Immediately after surgery, patients experience reduced stamina and temporary breathlessness on exertion. Over several months, the remaining lung tissue expands into the space, and the chest wall adapts. Most patients regain 80 to 90 percent of their preoperative breathing capacity, aided by pulmonary rehabilitation.
Unlike cosmetic treatments, realistic outcomes are measured by pathology rather than visual before-and-after photographs. Within 5 to 7 days, the histopathology report confirms tumour dimensions, cell type, surgical margin clearance and lymph node status. This report determines whether resection was curative or if adjuvant systemic treatments, such as targeted therapy or chemotherapy, are recommended by the multidisciplinary oncology board.
A pulmonary lobectomy is a major thoracic operation. Based on published data from the British Thoracic Society (BTS), Society of Thoracic Surgeons (STS) and the NHS, potential complications include:
Hospitals minimise these risks through single-use vascular staplers, multi-modal analgesia and early post-operative mobilisation.
When evaluating lobectomy Turkey providers, safety requires choosing an accredited tertiary hospital with full surgical infrastructure. Verify that the facility provides:
Red flags include agencies offering quotes without reviewing CT scans or lung function reports, clinics lacking an intensive care unit, or coordinators who cannot name the operating surgeon. Learn about international treatment logistics through how our process works and submit records via our free quote page.
A lobectomy is a major surgical operation to remove an entire anatomical lobe of an organ, most commonly the lung. The human lungs have five lobes: three on the right and two on the left. The surgeon divides the blood vessels and airway supplying the diseased lobe and removes it intact, preserving the remaining healthy lung tissue.
When lung cancer is diagnosed at an early stage (stages I and II) and has not spread to distant sites, an anatomical lobectomy with lymph node dissection offers the highest curative rate among surgical treatments. Long-term outcomes depend on the final tumour pathology, stage and whether recommended adjuvant treatments like chemotherapy or immunotherapy are completed.
A lobectomy in Turkey typically ranges from €7,500 to €16,000, depending on whether it is performed via minimally invasive VATS or open thoracotomy, the required intensive care stay and pathology testing. In the UK and Germany, private costs often range between €16,000 and €34,000, while US private charges frequently exceed €35,000.
Initial hospital recovery takes 4 to 7 days, during which chest drains are removed and walking begins. Most patients can travel home after 12 to 14 days following a fit-to-fly assessment. Returning to sedentary work generally takes 4 to 6 weeks, while full physical stamina and breathing recovery require 3 to 6 months.
Because incisions involve the chest wall and ribs, post-operative discomfort is expected. Modern thoracic centres manage this using multi-modal pain control, including epidural analgesia, intercostal nerve blocks, patient-controlled analgesia (PCA) pumps and oral pain relief. Pain gradually eases over several weeks as surgical incisions and surrounding chest tissues heal.
A lobectomy removes only one lobe of the lung, preserving the remaining lobes and maintaining most of your breathing capacity. A pneumonectomy involves the surgical removal of the entire lung. Surgeons always attempt a lobectomy or smaller resection whenever oncologically feasible, reserving pneumonectomy for large central tumours that cannot otherwise be cleared.
Before surgery, you will undergo thorough cardiopulmonary testing and imaging to ensure suitability. After surgery, your remaining lung tissue expands to fill the chest cavity. Although you may feel breathless during early exertion, structured pulmonary rehabilitation helps most patients regain 80 to 90 percent of their normal physical capacity over several months.
A lobectomy is a major thoracic operation with well-established safety protocols. When performed by experienced thoracic surgical teams in accredited hospitals with modern intensive care units, mortality rates are low (typically 1 to 2 percent). Common manageable risks include temporary air leaks, minor heart rhythm changes and chest infections, which are monitored closely.
Yes, most individuals lead an active and normal life after recovering from a lobectomy. The remaining lobes expand and adapt over time. While competitive athletics or extreme high-altitude activities may be limited depending on baseline health, everyday routines, walking, travel and work are fully manageable for the vast majority of patients.
Patients typically need to stay in Turkey for 12 to 16 days. This duration covers preoperative staging and cardiopulmonary tests (1 to 2 days), the inpatient hospital stay (4 to 7 days) and outpatient hotel recovery with follow-up chest X-rays to obtain formal fit-to-fly clearance before boarding an aircraft.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.